{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T04:46:10Z","timestamp":1784263570514,"version":"3.55.0"},"publisher-location":"New York, NY","reference-count":37,"publisher":"Springer US","isbn-type":[{"value":"9781071631744","type":"print"},{"value":"9781071631751","type":"electronic"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-1-0716-3175-1_36","type":"book-chapter","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T07:02:13Z","timestamp":1684479733000},"page":"549-565","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["ADAMTS13 Antibody and Inhibitor Assays"],"prefix":"10.1007","author":[{"given":"Gary W.","family":"Moore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helga","family":"Vetr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaus B.","family":"Binder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,20]]},"reference":[{"key":"36_CR1","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1182\/blood-2016-10-709857","volume":"129","author":"BS Joly","year":"2017","unstructured":"Joly BS, Coppo P, Veyradier A (2017) Thrombotic thrombocytopenic purpura. Blood 129:2836\u20132846","journal-title":"Blood"},{"key":"36_CR2","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1146\/annurev-med-061813-013241","volume":"66","author":"XL Zheng","year":"2015","unstructured":"Zheng XL (2015) ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura. Annu Rev Med 66:211\u2013225","journal-title":"Annu Rev Med"},{"key":"36_CR3","doi-asserted-by":"publisher","first-page":"536","DOI":"10.3390\/jcm10030536","volume":"10","author":"S Sukumar","year":"2021","unstructured":"Sukumar S, L\u00e4mmle B, Cataland SR (2021) Thrombotic thrombocytopenic purpura: pathophysiology, diagnosis, and management. J Clin Med 10:536","journal-title":"J Clin Med"},{"key":"36_CR4","doi-asserted-by":"publisher","first-page":"E153","DOI":"10.1503\/cmaj.160142","volume":"189","author":"DM Arnold","year":"2017","unstructured":"Arnold DM, Patriquin CJ, Nazy I (2017) Thrombotic microangiopathies: a general approach to diagnosis and management. CMAJ 189:E153\u2013E159","journal-title":"CMAJ"},{"key":"36_CR5","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1111\/j.1538-7836.2006.02025.x","volume":"4","author":"SG Shelat","year":"2006","unstructured":"Shelat SG, Smith P, Ai J, Zheng XL (2006) Inhibitory autoantibodies against ADAMTS-13 in patients with thrombotic thrombocytopenic purpura bind ADAMTS-13 protease and may accelerate its clearance in vivo. J Thromb Haemost 4:1707\u20131717","journal-title":"J Thromb Haemost"},{"key":"36_CR6","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.1182\/blood-2003-05-1616","volume":"102","author":"F Scheiflinger","year":"2003","unstructured":"Scheiflinger F, Kn\u00f6bl P, Trattner B et al (2003) Nonneutralizing IgM and IgG antibodies to von Willebrand factor-cleaving protease (ADAMTS-13) in a patient with thrombotic thrombocytopenic purpura. Blood 102:3241\u20133243","journal-title":"Blood"},{"key":"36_CR7","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.ebiom.2015.06.007","volume":"2","author":"MR Thomas","year":"2015","unstructured":"Thomas MR, de Groot R, Scully MA, Crawley JT (2015) Pathogenicity of anti-ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpura. EBioMedicine 2:942\u2013952","journal-title":"EBioMedicine"},{"key":"36_CR8","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1182\/bloodadvances.2020004172","volume":"5","author":"K Kangro","year":"2021","unstructured":"Kangro K, Roose E, Joly BS et al (2021) Anti-ADAMTS13 autoantibody profiling in patients with immune-mediated thrombotic thrombocytopenic purpura. Blood Adv 5:3427\u20133435","journal-title":"Blood Adv"},{"key":"36_CR9","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1111\/jth.15297","volume":"19","author":"C Dekimpe","year":"2021","unstructured":"Dekimpe C, Roose E, Kangro K et al (2021) Determination of anti-ADAMTS-13 autoantibody titers in ELISA: influence of ADAMTS-13 presentation and autoantibody detection. J Thromb Haemost 19:2248\u20132255","journal-title":"J Thromb Haemost"},{"key":"36_CR10","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1182\/asheducation-2018.1.530","volume":"2018","author":"T Chiasakul","year":"2018","unstructured":"Chiasakul T, Cuker A (2018) Clinical and laboratory diagnosis of TTP: an integrated approach. Hematology Am Soc Hematol Educ Program 2018:530\u2013538","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"36_CR11","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1111\/jth.15006","volume":"18","author":"XL Zheng","year":"2020","unstructured":"Zheng XL, Vesely SK, Cataland SR et al (2020) ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura. J Thromb Haemost 18:2486\u20132495","journal-title":"J Thromb Haemost"},{"key":"36_CR12","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1111\/bjh.13654","volume":"171","author":"S Hassan","year":"2015","unstructured":"Hassan S, Westwood JP, Ellis D, Laing C, Mc Guckin S, Benjamin S, Scully M (2015) The utility of ADAMTS13 in differentiating TTP from other acute thrombotic microangiopathies: results from the UK TTP Registry. Br J Haematol 171:830\u2013835","journal-title":"Br J Haematol"},{"key":"36_CR13","doi-asserted-by":"publisher","first-page":"546","DOI":"10.5858\/arpa.2013-0170-OA","volume":"138","author":"BD Barrows","year":"2014","unstructured":"Barrows BD, Teruya J (2014) Use of the ADAMTS13 activity assay improved the accuracy and efficiency of the diagnosis and treatment of suspected acquired thrombotic thrombocytopenic purpura. Arch Pathol Lab Med 138:546\u2013549","journal-title":"Arch Pathol Lab Med"},{"key":"36_CR14","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/trf.13359","volume":"56","author":"NT Connell","year":"2016","unstructured":"Connell NT, Cheves T, Sweeney JD (2016) Effect of ADAMTS13 activity turnaround time on plasma utilization for suspected thrombotic thrombocytopenic purpura. Transfusion 56:354\u2013359","journal-title":"Transfusion"},{"key":"36_CR15","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1111\/bjh.15219","volume":"184","author":"W Thomas","year":"2019","unstructured":"Thomas W, Cutler JA, Moore GW, McDonald V, Hunt BJ (2019) The utility of a fast turnaround ADAMTS13 activity in the diagnosis and exclusion of thrombotic thrombocytopenic purpura. Br J Haematol 184:1026\u20131032","journal-title":"Br J Haematol"},{"key":"36_CR16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/rth2.12461","volume":"5","author":"N Beranger","year":"2020","unstructured":"Beranger N, Benghezal S, Joly BS et al (2020) Diagnosis and follow-up of thrombotic thrombocytopenic purpura with an automated chemiluminescent ADAMTS13 activity immunoassay. Res Pract Thromb Haemost 5:81\u201393","journal-title":"Res Pract Thromb Haemost"},{"key":"36_CR17","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/ijlh.13295","volume":"42","author":"I Mackie","year":"2020","unstructured":"Mackie I, Mancini I, Muia J, Kremer Hovinga J, Nair S, Machin S, Baker R (2020) International Council for Standardization in Haematology (ICSH) recommendations for laboratory measurement of ADAMTS13. Int J Lab Hematol 42:685\u2013696","journal-title":"Int J Lab Hematol"},{"key":"36_CR18","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3324\/haematol.11739","volume":"93","author":"F Peyvandi","year":"2008","unstructured":"Peyvandi F, Lavoretano S, Palla R et al (2008) ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission. Haematologica 93:232\u2013239","journal-title":"Haematologica"},{"key":"36_CR19","doi-asserted-by":"publisher","first-page":"e329","DOI":"10.1055\/s-0038-1672187","volume":"2","author":"C Vendramin","year":"2018","unstructured":"Vendramin C, Thomas M, Westwood JP, Scully M (2018) Bethesda assay for detecting inhibitory anti-ADAMTS13 antibodies in immune-mediated thrombotic thrombocytopenic purpura. TH Open 2:e329\u2013e333","journal-title":"TH Open"},{"issue":"Suppl 1","key":"36_CR20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/ijlh.13557","volume":"43","author":"KJ Smock","year":"2021","unstructured":"Smock KJ (2021) ADAMTS13 testing update: focus on laboratory aspects of difficult thrombotic thrombocytopenic purpura diagnoses and effects of new therapies. Int J Lab Hematol 43(Suppl 1):103\u2013108","journal-title":"Int J Lab Hematol"},{"key":"36_CR21","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/ijlh.12718","volume":"40","author":"K Langley","year":"2018","unstructured":"Langley K, Fretwell R, Kitchen S et al (2018) Multiple centre evaluation study of ADAMTS13 activity and inhibitor assays. Int J Lab Hematol 40:21\u201325","journal-title":"Int J Lab Hematol"},{"key":"36_CR22","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1111\/jth.12881","volume":"13","author":"AR Hubbard","year":"2015","unstructured":"Hubbard AR, Heath AB, Kremer Hovinga JA, Subcommittee on von Willebrand Factor (2015) Establishment of the WHO 1st International Standard ADAMTS13, plasma (12\/252): communication from the SSC of the ISTH. J Thromb Haemost 13:1151\u20131153","journal-title":"J Thromb Haemost"},{"key":"36_CR23","doi-asserted-by":"publisher","unstructured":"Favaloro EJ, Chapman K, Mohammed S, Vong R, Pasalic L (2023) Identification of ADAMTS13 inhibitors in acquired TTP. In: Favaloro EJ, Gosselin RC (eds) Hemostasis and thrombosis: methods and protocols. Methods in molecular biology. Springer, New York, pp 505\u2013521. https:\/\/doi.org\/10.1007\/978-1-0716-3175-1_33","DOI":"10.1007\/978-1-0716-3175-1_33"},{"key":"36_CR24","doi-asserted-by":"publisher","unstructured":"Moore GW, Lusa M, Griffiths M, Binder NB (2023) ADAMTS13 activity measurement by ELISA and fluorescence resonance energy transfer assay. In: Favaloro EJ, Gosselin RC (eds) Haemostasis and thrombosis: methods and protocols, 2nd edn. Springer, New York, pp 533\u2013547. https:\/\/doi.org\/10.1007\/978-1-0716-3175-1_35","DOI":"10.1007\/978-1-0716-3175-1_35"},{"key":"36_CR25","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/j.1365-2141.2006.06471.x","volume":"136","author":"R Starke","year":"2007","unstructured":"Starke R, Machin S, Scully M, Purdy G, Mackie I (2007) The clinical utility of ADAMTS13 activity, antigen and autoantibody assays in thrombotic thrombocytopenic purpura. Br J Haematol 136:649\u2013655","journal-title":"Br J Haematol"},{"key":"36_CR26","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1182\/blood-2016-12-758656","volume":"130","author":"F Alwan","year":"2017","unstructured":"Alwan F, Vendramin C, Vanhoorelbeke K et al (2017) Presenting ADAMTS13 antibody and antigen levels predict prognosis in immune-mediated thrombotic thrombocytopenic purpura. Blood 130:466\u2013471","journal-title":"Blood"},{"key":"36_CR27","unstructured":"Moore GW, Griffiths M, Binder NB (2022) Diagnostic potential of rapid automated ADAMTS13 inhibitor screening and quantification. Poster presentation at Congress of the Society for Thrombosis and Hemostasis Research (GTH), Congress Centre, Leipzig, 1-4 March, 2022"},{"key":"36_CR28","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001598","volume":"94","author":"Roriz M, Landais M, Desprez J, et al; French Thrombotic Microangiopathies Reference Center","year":"2015","unstructured":"Roriz M, Landais M, Desprez J, et al; French Thrombotic Microangiopathies Reference Center (2015) Risk factors for autoimmune diseases development after thrombotic thrombocytopenic purpura. Medicine (Baltimore) 94:e1598","journal-title":"Medicine (Baltimore)"},{"key":"36_CR29","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1056\/NEJM199811263392202","volume":"339","author":"M Furlan","year":"1998","unstructured":"Furlan M, Robles R, Galbusera M et al (1998) von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 339:1578\u20131584","journal-title":"N Engl J Med"},{"key":"36_CR30","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","volume":"339","author":"HM Tsai","year":"1998","unstructured":"Tsai HM, Lian EC (1998) Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 339:1585\u20131594","journal-title":"N Engl J Med"},{"key":"36_CR31","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/j.1365-2141.2004.05217.x","volume":"127","author":"F Peyvandi","year":"2004","unstructured":"Peyvandi F, Ferrari S, Lavoretano S, Canciani MT, Mannucci PM (2004) von Willebrand factor cleaving protease (ADAMTS-13) and ADAMTS-13 neutralizing autoantibodies in 100 patients with thrombotic thrombocytopenic purpura. Br J Haematol 127:433\u2013439","journal-title":"Br J Haematol"},{"key":"36_CR32","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/ijlh.12542","volume":"38","author":"MO Nakashima","year":"2016","unstructured":"Nakashima MO, Zhang X, Rogers HJ, Vengal L, Gibson B Jr, Daly TM, Kottke-Marchant K (2016) Validation of a panel of ADAMTS13 assays for diagnosis of thrombotic thrombocytopenic purpura: activity, functional inhibitor, and autoantibody test. Int J Lab Hematol 38:550\u2013559","journal-title":"Int J Lab Hematol"},{"key":"36_CR33","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/ijlh.13359","volume":"43","author":"M Jacquemin","year":"2021","unstructured":"Jacquemin M, Van Horenbeeck I et al (2021) Optimization of the detection of inhibitory autoantibodies against the VWF-cleaving protease ADAMTS13 with an automated chemiluminescent ADAMTS13 activity immunoassay. Int J Lab Hematol 43:290\u2013297","journal-title":"Int J Lab Hematol"},{"key":"36_CR34","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1111\/j.1538-7836.2012.04744.x","volume":"10","author":"I Mancini","year":"2012","unstructured":"Mancini I, Valsecchi C, Palla R, Lotta LA, Peyvandi F (2012) Measurement of anti-ADAMTS13 neutralizing autoantibodies: a comparison between CBA and FRET assays. J Thromb Haemost 10:1439\u20131442","journal-title":"J Thromb Haemost"},{"key":"36_CR35","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1002\/ajh.26241","volume":"96","author":"EJ Favaloro","year":"2021","unstructured":"Favaloro EJ, Pasalic L, Henry B, Lippi G (2021) Laboratory testing for ADAMTS13: utility for TTP diagnosis\/exclusion and beyond. Am J Hematol 96:1049\u20131055","journal-title":"Am J Hematol"},{"key":"36_CR36","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1182\/bloodadvances.2018018432","volume":"2","author":"JN George","year":"2018","unstructured":"George JN (2018) The remarkable diversity of thrombotic thrombocytopenic purpura: a perspective. Blood Adv 2:1510\u20131516","journal-title":"Blood Adv"},{"key":"36_CR37","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3324\/haematol.2011.051433","volume":"97","author":"R Froehlich-Zahnd","year":"2012","unstructured":"Froehlich-Zahnd R, George JN, Vesely SK et al (2012) Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura. Haematologica 97:297\u2013303","journal-title":"Haematologica"}],"container-title":["Methods in Molecular Biology","Hemostasis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-3175-1_36","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T07:07:19Z","timestamp":1684480039000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-3175-1_36"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9781071631744","9781071631751"],"references-count":37,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-3175-1_36","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"20 May 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}